News
Videos
Conferences
Events
Resources
Subscribe

|Articles|March 7, 2013

Being a “bad” patient

Author(s)Elizabeth Whittington

Newsletter

Stay up to date on cancer updates, research and education

Related Content

lung cancer

Tiragolumab Plus Tecentriq Doesn’t Improve NSCLC Outcomes

ByJason M Broderick

October 19th 2025

breast cancer

HR+/HER2- Metastatic Breast Cancer Progression Improved With Sac-TMT

ByAndrea Eleazar, MHS

October 19th 2025

breast cancer

Presurgical Enhertu Combo Elicits Response Benefit in HER2+ Early Breast Cancer

October 19th 2025

skin cancer

Similar Incidence of Second Primary Tumors After Libtayo or Placebo for CSCC

ByJax DiEugenio

October 18th 2025

breast cancer

Enhertu Reduces Risk of Invasive Disease or Death in HER2+ Breast Cancer

ByAshling Wahner

October 18th 2025

Trending on CURE

HR+/HER2- Metastatic Breast Cancer Progression Improved With Sac-TMT

Kisqali Plus Aromatase Inhibitor Shows Long-Term Benefit in Early Breast Cancer

Imdelltra Improves Survival For Some With Small Cell Lung Cancer

Keytruda Combo Improves Progression, Survival in Recurrent Ovarian Cancer

Tiragolumab Plus Tecentriq Doesn’t Improve NSCLC Outcomes

© 2025 MJH Life Sciences^®

All rights reserved.